Asiklik bir nükleotid analoğu olan tenofovir disoproksil fumarat, hepatit B tedavisi için 2008 yılında onaylanan antiviral bir ilaçtır. Bilinen en sık yan etkileri; bulantı, kusma, diyare, nefrotoksisite ve hepatotoksisitedir. Fakat cilt tutulumu olan yan etkiler nadir görülür. Kutanöz lökositoklastik vaskülit ise birçok ilaca bağlı olarak görülebilmekle birlikte tenofovirin indüklediği olgu daha önce hiç bildirilmemiştir.
Introduction
Cutaneous leukocytoclastic vasculitis (LCV) is the inflammation of small blood vessels and may be secondary to drugs, infections, malignity, and connective tissue disorders [1] . Tenofovir is generally well tolerated. Most common side effects are related to the gastrointestinal system [2] . Nephrotoxicity and hepatotoxicity are less common. However, side effects, involving the skin, are rare [3] . In our knowledge, LCV case due to tenofovir has not been reported yet. Here, we present a case with LCV, which developed at the first month of tenofovir treatment.
Case Report
A 59 years-old male patient with chronic hepatitis B and cirrhosis admitted to our hospital with widespread itching, particularly at lower extremities. Medical history revealed that complaints of the patient started in the first month of tenofovir treatment, and no other medications were used. He had no complaint other than weakness, and itching; he had no fever, oral or genital ulcers, photosensitivity, arthralgia; and he did not take any herbal treatments. Physical examination revealed that heart beat was 82 bpm, blood pressure was 110/70 mmHg, respiratory rate was 16/min, and body temperature was 36.7 °C. There were no palpable lymph nodes. Hyperpigmented macular lesions of 0.5 cm in diameter were present in both lower extremities, particularly on anterior of tibias ( Figure 1 ). Remaining physical examination findings were normal. Complete blood count, hepatic, renal and thyroid function tests, erythrocyte sedimentation rate and C-reactive protein were normal. Other laboratory findings are summarized in the table. Skin biopsy was performed after learning that previous antihistaminic treatment did not work, which was recommended by a dermatologist. Biopsy result was reported as mild, and partly moderate inflammatory infiltrate at perivascular localization in the subepidermal region beneath the epidermis, which included lymphocytes as well as high numbers of polymorphic nucleated leucocytes. Partial leukocytoclastic foci were observed, and capillary endothelium made explicit. Additionally, few numbers of extravasated erythrocytes were seen in the interstitium. These findings were compatible with LCV ( Figure 2 ). Possible etiologies for LCV include infectious diseases, malignity, and collagen tissue disorders. Since he was on follow-up for chronic hepatitis B, HBV DNA was analyzed, but found negative. Other viral indicators were also negative (Table) . Pathogen microorganisms were not found in stool, throat, and sputum cultures. Urine cultures were also negative. Thoraco-abdominal tomography did not reveal positive findings for infectious diseases or malignity. There were no pathological findings other than esophageal varices in upper gastrointestinal system endoscopy. Colonoscopy did not reveal findings of chronic inflammatory bowel disease or malignity. There was no finding regarding collagen tissue disorders. Serologic indicators for collagen tissue diseases and other vasculitis are presented in Table. Only cytoplasmic antinuclear antibody was found positive. The diseases that might be responsible for the etiology were all eliminated, and the only drug that patient used, tenofovir, was stopped and replaced with entecavir. Itching and cutaneous lesions regressed after two weeks of drug exchange, and no new lesions were observed. 
Serologic Markers
Rheumatoid factor (IU/L) Negative Anti-nuclear antibody Negative P-ANCA Negative
C-ANCA Positive

Discussion
Leukocytoclastic vasculitis is a small-vessel vasculitis that is characterized by neutrophilic infiltration in cutaneous superficial postcapillary venules. It may be idiopathic, and may also be related to infections, drugs, collagen tissue diseases, and malignities [1] . The case presented here had no suspected disease in the etiology. Small-vessel vasculitis are evaluated under two headings either antineutrophil cytoplasmic antibody (ANCA) positive or ANCA negative. These antibodies are autoantibodies that target lysosomal enzymes of neutrophils and grouped as c-ANCA that is against proteinase, and p-ANCA that is against myeloperoxidase [4] . ANCA positive small-vessel vasculitis are classified under four groups as microscopic polyangiitis, Wegener's granulomatosis, Churg-Strauss syndrome, and drug-induced vasculitis [5] . Drug-induced small-vessel vasculitis constitutes about 10%, and most commonly responsible drugs are penicillin, aminopenicillin, sulphonamides, allopurinol, quinolone, thiazides, hydantoin, and propylthiouracil [5] . They develop approximately after 7 to 21 days of drug initiation [6] . In our case, leukocytoclastic vasculitis has developed due to tenofovir, which has not been reported before and has developed one month after the initiation of the drug. More commonly palpable purpura, especially in lower extremities, and less commonly urticarial, vesicular, nodular, and target-like lesions, livedoid pattern, and ulcerations are seen clinically [1] . Constitutional symptoms, arthralgia, myalgia, and other symptoms related to internal organ involvement are also seen in patients [7] . Itching is present rarely [8] . In this case, the main complaint of the patient was itching, and purpura. Tenofovir related leukocytoclastic vasculitis case has not been reported previously. Diagnose of this case was based on elimination of other causes, tenofovir being the only medication, and regression of lesions after changing this drug.
Tenofovir is a nucleotide analogue and widely used for chronic hepatitis B and antiretroviral treatment. It is a quite safe drug, but adverse events like nausea, vomiting, diarrhea, hepatotoxicity, nephrotoxicity, pancreatitis, Fanconi anemia, and diabetes insipidus were reported. Maculopapular rashes, urticarial rashes, vesiculopustular lesions, and lichenoid drug eruptions are rarely reported [3] . Also, tenofovir related itching is very rare [8] . The ideal way of treatment of cutaneous side effects related with tenofovir is not known. In a previous report of a case with skin eruptions, lesions were reported to regress ten days after the drug discontinuation [8] . In our case, no additional treatment was given, and itching complaint and lesions were resolved within two weeks after drug withdrawal. Increasing number or reports will help to constitute a common approach regarding the management of these cases. Leukocytoclastic vasculitis is diagnosed by histopathological evaluation of the biopsy from the lesion, and additional laboratory tests should be performed for systemic involvement and its etiology. Drugs might play a role in the etiology of LCV. Although it has not been reported before, LCV may develop on tenofovir use as can be seen in this case. One should be careful with the cutaneous lesions that develop during medication use and appropriate diagnostic methods, and the differential diagnoses should be kept in mind to manage the treatment.
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